LoreaTec BizSearch
English|日本語

株式会社レナサイエンス

Miyagi, Japan

Active
Registration numberT1012301007259
TypeCorporation
Registered name株式会社レナサイエンス
Address宮城県仙台市青葉区星陵町2番1号
2-1 Seiryomachi, Sendai-shi Aoba-ku, Miyagi 980-0872, JAPAN
Corporate number1012301007259
Corporate number assigned on2015-10-05
Invoice registered on2023-10-01
Record last updated2025-03-06

The invoice registration date is when the qualified-invoice-issuer registration (T-number) took effect — it is not the date the company was founded, and it resets only if the business re-registers after revocation or expiry.

Corporate registry record

Entity typeKabushiki Kaisha (stock company)
Representative代表取締役会長兼社長 宮田 敏男
Reading (furigana)レナサイエンス
Reading (romaji)Renasaiensu
English name (unofficial)Rena Science K.K.
Postal code980-0872

Source: NTA Corporate Number Publication Site, refreshed daily. Representative: gBizINFO (METI, monthly).

Company profile (gBizINFO)

Employees3
Capital¥1.98B

Source: gBizINFO (METI), refreshed monthly — edited extract by LoreaTec. Figures are as filed by each company.

Timeline — registry changes

2024-10-08Head-office address changed (Japan)

Source: daily change files of the NTA Corporate Number Publication Site. Before 2023-08-16 only the latest change is known. All company events →

Government contract awards (GEPS)

No public national-government (GEPS) award records for this company in the open data (FY2013 to date).

Browse the awards database →

出典:調達ポータル(https://www.p-portal.go.jp/)

Payments from national budget programmes (行政事業レビュー)

Ministry review sheets report this company as a payee of 2 programmes (3 lines, sheet years 2024–2025; total ¥128.9M).

2025
FY2024
医工連携イノベーション推進事業 ¥40.9M (経済産業省)
事業管理機関、研究開発計画の運営、医療機器の開発・改良、臨床評価・実用化
2024
FY2023
医工連携イノベーション推進事業 ¥47.7M (経済産業省)
事業管理機関/研究開発計画の運営/医療機器の開発・改良/臨床評価・実用化
2024
FY2023
橋渡し研究プログラム ¥40.3M (文部科学省)
研究開発の実施

Contract details (excerpt): 糖尿病患者のインスリン投与量を予測する人工知能(AI)の開発(補助事業) ¥40.9M・補助金等交付 · bidders 0 / 糖尿病患者のインスリン投与量を予測する人工知能(AI)の開発・事業化 ¥47.7M・その他 · bidders 0 / 進行性悪性黒色腫治療における抗PD-1抗体とのTM5614の安全性・有効性を検討する第II相試験 ¥40.3M · bidders 0

Source: 行政事業レビュー見える化サイト (Cabinet Secretariat, PDL 1.0) — edited extract by LoreaTec. A sheet year describes the previous fiscal year’s spending. Programme database →

Doing due diligence on this supplier?

Verifying the invoice number is step one. Our guide covers the full checklist: corporate registry, licenses, and import/export standing.

Read the guide

How to cite this page

Data via LoreaTec BizSearch (https://bizsearch.loreatec.jp/t1012301007259) — Source: National Tax Agency corporate-number and qualified-invoice registries. Retrieved 2026-09-21.

Reusing this page, or answering with it? Paste this line. Training and AI answers are allowed — attribution is the only condition. AI content licence